Form 4: Q32 Bio CFO Sells Shares

Lee Kalowski, CFO and President of Q32 Bio Inc., reported the sale of 9,072 shares of common stock at $3.4607 per share, reducing his direct beneficial ownership to 39,938 shares.

Summary

• Lee Kalowski, the Chief Financial Officer and President of Q32 Bio Inc. (QTTB), reported a transaction involving the company's common stock.
• On December 2, 2025, Kalowski disposed of 9,072 shares of Q32 Bio Inc. common stock.
• The shares were sold at a price of $3.4607 per share.
• Following this transaction, Kalowski directly beneficially owns 39,938 shares of Q32 Bio Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale, likely pre-planned under Rule 10b5-1, which typically carries a neutral sentiment as it's not indicative of new company-specific positive or negative developments.

Future Outlook

This Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a standard regulatory disclosure of an insider stock transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• The sale by a key executive, while pre-planned, slightly reduces management's direct equity stake, which could be noted by shareholders but is unlikely to have a significant impact given the routine nature of such disclosures.

Key Dates

Keywords

Q32 Bio Inc., QTTB, Lee Kalowski, CFO, President, Insider Trading, Form 4, Stock Sale, Beneficial Ownership, Rule 10b5-1